Baltimore, MD, United States of America

Maya Monroe

This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maya Monroe: Innovator in Antiviral Therapeutics

Introduction

Maya Monroe is a distinguished inventor based in Baltimore, MD. She has made significant contributions to the field of antiviral therapeutics, showcasing her innovative spirit and dedication to improving healthcare.

Latest Patents

Maya Monroe holds a patent for her groundbreaking work on self-assembling antiviral prodrugs. This patent discloses therapeutic self-assembling molecules that include a peptide sequence conjugated to one or more antiviral therapeutics. These molecules form a peptide-based antiviral prodrug capable of self-assembly into supramolecular structures with varying morphology in aqueous solutions. This innovative approach allows for subcutaneous or intramuscular injection, providing a long-acting treatment option for chronic viral infections.

Career Highlights

Maya is affiliated with The Johns Hopkins University, where she continues to advance her research in antiviral therapies. Her work is characterized by a commitment to developing novel solutions that address pressing health challenges.

Collaborations

Maya collaborates with esteemed colleagues, including Honggang Cui and Charles Williams Flexner. These partnerships enhance her research and contribute to the advancement of antiviral therapeutics.

Conclusion

Maya Monroe's innovative work in the field of antiviral therapeutics exemplifies her dedication to improving health outcomes. Her contributions through her patent and collaborations position her as a key figure in the ongoing fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…